Most current researchers agree that provider communication has the potential to significantly increase patient compliance
Pharmaceutical devices will continue to drive patient compliance
and acceptability as increased options make for a wider choice.
By making MR exams more comfortable, patient compliance
, exam efficiency and technologist productivity are improved.
Almac will also feature new enhancements to its Patient Compliance
service offering at the DIA Conference.
The respondents were queried about factors affecting the prescription of eye-care medications, the brands that they patronize, patient compliance
with the instructions given to them for taking medications, and the number of medications taken by patients.
Connie Commander, immediate past president of the Case Management Society of America and president, Commander's Premier Consulting Corporation, and Thom Stambaugh, chief pharmacy officer and vice president of clinical programs and specialty pharmacy, CIGNA Pharmacy Management, described programs and initiatives that have increased patient compliance
with medication regimes.
The Patient Compliance
Europe Conference, organised by eyeforpharma and held in Amsterdam on 1-2 June 2006, explored the major issues surrounding patient compliance
, showcasing research and case studies from major European pharmaceutical companies and how they are addressing the problem.
in the healthcare and pharmaceutical industries takes center stage when VoicePort launches its PharmaPhonetics[TM] Patient Adherence at CBI's 7th Annual Forum on Patient Compliance
, Adherence and Persistency today at the Doubletree hotel in Philadelphia, PA.
Currently available drugs, which also reduce dopamine activity, induce significant clinical side effects, thereby limiting patient compliance
setting the scene, Dr Faiz Kermani and Dr Madhu Davies
The report, Improving Patient Compliance
in Clinical Trials, concludes that adoption of compliance technology will increase as acquisition and implementation costs decline.
Growth has also been driven by the launch of new non-stimulant drugs, new patients and the development of new formulations providing flexibility in dosing and higher patient compliance